| |
Latest 10 SEC filings (by transaction date) for RYTM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 8,905 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -6,874 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -2,031 | |
Apr 16/24 | Apr 14/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,375 | |
Apr 16/24 | Apr 14/24 | Mazabraud Yann | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | -10,375 | |
Apr 3/24 | Apr 2/24 | German Christopher Paul | Direct Ownership | Common Stock | S - Open market or private sale | -368 | $41.76 |
Mar 22/24 | Mar 21/24 | Shulman Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -18,235 | $40.34 |
Apr 3/24 | Mar 20/24 | German Christopher Paul | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -1,163 | |
Apr 3/24 | Mar 20/24 | German Christopher Paul | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,163 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RYTM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 10,000 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | A - Grant, award or other under Rule 16b-3(d) | 8,905 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -6,874 | |
Apr 16/24 | Apr 15/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | D - Disposition to issuer under Rule 16b-3(e) | -2,031 | |
Apr 16/24 | Apr 14/24 | Mazabraud Yann | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,375 | |
Apr 16/24 | Apr 14/24 | Mazabraud Yann | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | -10,375 | |
Apr 3/24 | Mar 20/24 | German Christopher Paul | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -1,163 | |
Apr 3/24 | Apr 2/24 | German Christopher Paul | Direct Ownership | Common Stock | S - Open market or private sale | -368 | $41.76 |
Apr 3/24 | Mar 20/24 | German Christopher Paul | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,163 | |
Mar 22/24 | Mar 21/24 | Shulman Joseph | Direct Ownership | Common Stock | S - Open market or private sale | -18,235 | $40.34 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |